Literature DB >> 30578499

Leber Congenital Amaurosis.

Stephen H Tsang1,2, Tarun Sharma3.   

Abstract

Leber congenital amaurosis (LCA) is a part of the spectrum of early-onset retinal dystrophy (EORD). It usually presents in the first few years of life, most often before the age of 1 year. The prevalence is about 1:80,000. Also known as congenital retinitis pigmentosa (RP), patients have wandering nystagmus, with reduced vision from birth. The fundus is almost normal to start with. Later, pigmentary disturbances develop. The best corrected visual acuity (BCVA) ranges from no light perception (in nearly one third of cases) to no better than 20/400, often with a hyperopic refraction (≥5.0D). Patients have absent pupillary reflex and some of them have keratoconus (CRB1 and AIPL1). Oculodigital reflex (eye rubbing or poking) is a common association. Electroretinography (ERG) responses are almost undetectable. Patients may have normal intelligence, but some studies suggest that as many as 20% of children with LCA without associated anomalies develop intellectual disability. Patients with GUCY2D mutations have a stable clinical course; those with RPE65 mutations show a period of limited improvement followed by progressive deterioration; and those with AIPL1, CRB1, CEP290, and NMNAT1 mutations show gradual progression over several decades.

Entities:  

Keywords:  Autosomal recessive; Leber congenital amaurosis

Mesh:

Year:  2018        PMID: 30578499     DOI: 10.1007/978-3-319-95046-4_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  14 in total

1.  Associations Between Fundus Types and Clinical Manifestations in Patients with RDH12 Gene Mutations.

Authors:  Jing Jin; Liang Liang; Kun Jin; Hai-Jiang Zhang; Rong Liu; Yin Shen
Journal:  Brain Topogr       Date:  2022-01-10       Impact factor: 4.275

2.  Real-world outcomes of voretigene neparvovec treatment in pediatric patients with RPE65-associated Leber congenital amaurosis.

Authors:  Callie Deng; Peter Y Zhao; Kari Branham; Dana Schlegel; Abigail T Fahim; Thiran K Jayasundera; Naheed Khan; Cagri G Besirli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-01-10       Impact factor: 3.535

Review 3.  Endoplasmic reticulum stress: New insights into the pathogenesis and treatment of retinal degenerative diseases.

Authors:  Marina S Gorbatyuk; Christopher R Starr; Oleg S Gorbatyuk
Journal:  Prog Retin Eye Res       Date:  2020-04-06       Impact factor: 21.198

Review 4.  Patient iPSC-derived retinal organoids: Observable retinal diseases in-a-dish.

Authors:  Xiao-Hui Zhang; Zi-Bing Jin
Journal:  Histol Histopathol       Date:  2021-01-22       Impact factor: 2.303

Review 5.  Structure and dynamics of photoreceptor sensory cilia.

Authors:  Theodore G Wensel; Valencia L Potter; Abigail Moye; Zhixian Zhang; Michael A Robichaux
Journal:  Pflugers Arch       Date:  2021-05-28       Impact factor: 3.657

Review 6.  Retinal pigment epithelium 65 kDa protein (RPE65): An update.

Authors:  Philip D Kiser
Journal:  Prog Retin Eye Res       Date:  2021-10-02       Impact factor: 19.704

Review 7.  Why is NMNAT Protective against Neuronal Cell Death and Axon Degeneration, but Inhibitory of Axon Regeneration?

Authors:  Bor Luen Tang
Journal:  Cells       Date:  2019-03-21       Impact factor: 6.600

Review 8.  Inherited Retinal Diseases Due to RPE65 Variants: From Genetic Diagnostic Management to Therapy.

Authors:  Manar Aoun; Ilaria Passerini; Pietro Chiurazzi; Marianthi Karali; Irene De Rienzo; Giovanna Sartor; Vittoria Murro; Natalia Filimonova; Marco Seri; Sandro Banfi
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

Review 9.  Retinogenesis of the Human Fetal Retina: An Apical Polarity Perspective.

Authors:  Peter M J Quinn; Jan Wijnholds
Journal:  Genes (Basel)       Date:  2019-11-29       Impact factor: 4.096

Review 10.  Leber congenital amaurosis/early-onset severe retinal dystrophy: current management and clinical trials.

Authors:  Malena Daich Varela; Thales Antonio Cabral de Guimaraes; Michalis Georgiou; Michel Michaelides
Journal:  Br J Ophthalmol       Date:  2021-03-12       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.